Cargando…
Clinical Efficacy and Safety of Propranolol in the Prevention and Treatment of Retinopathy of Prematurity: A Meta-Analysis of Randomized Controlled Trials
Objective: To perform a meta-analysis of randomized controlled trials verifying clinical efficacy and safety of propranolol in pre-term newborns with retinopathy of prematurity (ROP). Methods: We searched the literature databases (Pubmed, Embase, The Cochrane Library, Web of Science, CNKI, WanFang,...
Autores principales: | Kong, Haibo B., Zheng, Guoyuan Y., He, Baomei M., Zhang, Ying, Zhou, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902715/ https://www.ncbi.nlm.nih.gov/pubmed/33643978 http://dx.doi.org/10.3389/fped.2021.631673 |
Ejemplares similares
-
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
por: Filippi, Luca, et al.
Publicado: (2019) -
Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491
por: Filippi, Luca, et al.
Publicado: (2010) -
Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis
por: Alva, Niza, et al.
Publicado: (2023) -
Risk Calculator for Retinopathy of Prematurity Requiring Treatment
por: Chaves-Samaniego, Maria J., et al.
Publicado: (2020) -
Case Report: Glaucoma in an Infant With Retinopathy of Prematurity
por: Lenis, Tamara Lee, et al.
Publicado: (2021)